ACR Alpine Capital Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Motors
GM
|
+$57.1M |
| 2 |
Magna International
MGA
|
+$56.8M |
| 3 |
Lumen
LUMN
|
+$39.7M |
| 4 |
Microsoft
MSFT
|
+$32.6M |
| 5 |
Citigroup
C
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$53.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$5.09M |
| 3 |
Comstock Resources
CRK
|
+$2.42M |
| 4 |
FLOW
SPX FLOW, Inc.
FLOW
|
+$2.25M |
| 5 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$936K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 27.35% |
| 2 | Financials | 25.28% |
| 3 | Consumer Discretionary | 18.52% |
| 4 | Energy | 8.7% |
| 5 | Healthcare | 8.08% |
Similar funds
ACR Alpine Capital Research's Q1 2022 Portfolio in Review
As of Q1 2022, ACR Alpine Capital Research held 37 positions worth $2.01B, up 8.2% from $1.86B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
ACR Alpine Capital Research deployed $229M of net new capital in Q1 2022, opening 5 new positions and adding to 21 existing holdings. Its largest new stake was AerCap: 47,000 shares worth $2.36M.
By sector, the portfolio is most concentrated in Communication Services at 27% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Chevron, an estimated $53.9M trimmed.
- ACR Alpine Capital Research's largest Q1 2022 buy was AerCap: 47,000 shares worth $2.36M.
- ACR Alpine Capital Research added most to General Motors in Q1 2022, an estimated $57.1M increase.
- ACR Alpine Capital Research's biggest Q1 2022 reduction was Chevron, cutting an estimated $53.9M.
- ACR Alpine Capital Research's ten largest holdings make up 86% of its $2.01B portfolio in Q1 2022.
- ACR Alpine Capital Research opened 5 new positions and closed 0 in Q1 2022.
- ACR Alpine Capital Research's portfolio value rose 8.2% quarter-over-quarter to $2.01B.
Based on ACR Alpine Capital Research's 13F filing for Q1 2022, filed 26 Apr 2022.